Announcements
WATERS CORPORATION SELECTS CLINIVATION GLOBAL 2.0.
World leader in analytical
laboratory instrumentations selects Global 2.0 to manage its medical
products approvals and submissions worldwide.
Framingham, MA, April 25, 2006 - clinivation, Inc. announced today that Waters Corporation (NYSE: WAT) has selected clinivation GlobalTM 2.0 software.
"Waters Corporation's products and services are synonymous
with quality and performance in analytical labs around the world,"
said Joseph Kozikowski, M.D., clinivation's Chief Executive Officer.
"We are delighted that Waters Corporation's management has selected
clinivation Global 2.0 to help them build and track their medical
product approvals and submissions worldwide," he continued.
Clinivation Global 2.0 software enables medical device companies to sell more products to more countries faster and easier than ever before. Global 2.0 is the first complete solution targeted at automating the business processes for medical device approvals worldwide.
About Waters Corporation
Waters Corporation holds worldwide leading positions in three complementary analytical technologies: liquid chromatography, mass spectrometry, and thermal analysis. These market segments account for $4.5 - $5.0 billion of the overall $20+ billion analytical instrumentation market.
For more information, visit www.waters.com
About clinivation, Inc.
Clinivation's business is productivity- taking the time and labor out of making better medical products.
Since 1999, our productivity software and solutions have delivered superior value to market leaders in medical devices, pharmaceuticals, and diagnostics.
Visit clinivation online at www.clinivation.com For further information, please contact:
|
